Arthur Combs, MD, FCCP, FCCM is a physician executive with over 20 years’ experience in academic clinical practice as an ICU Director. Since his fellowship at memorial Sloan-Kettering Cancer Center he has been appointed to the faculties of George Washington, Georgetown, Medical College of Pennsylvania and Washington University. Dr. Combs is also an honorary Fellow of the American Colleges of Chest Physicians and Critical Care Medicine. An author of numerous abstracts, editorials, original articles, scholarly reviews and book chapters, he is also a contributor to the 2nd edition of the Textbook of Critical Care Medicine.
Having been recruited to industry, he first served as Medical Director of Mallinckrodt’s $1.3 billion Respiratory Care business and subsequently as Executive Vice President of R&D. After the acquisition of Mallinckrodt, Dr. Combs served as a consultant to numerous medical products companies including HP Medical, Agilent, Philips Medical Systems, Edwards Life Sciences, SomaLogic, Kantar Health and Nova Biomedical. Between consulting engagements Dr. Combs has served as CMO for Everest Biomedical (sold to Stryker), and BMEYE, BV (sold to Edwards life Sciences). While at Everest he was co-inventor on the seminal patent for Brainscope later spun out as BrainScope, Inc. For more than 7 years Dr. Combs served as the CEO of Grove Instruments, Inc. raising more than $20 M and building the company from 4 to 20 employees and increasing valuation from 1 to $40 M pre-commercialization.
Dr. Combs brings 20 years of direct product development experience in medical devices. Many products have been cleared by the FDA to the US market on his watch (at Mallinckrodt, Everest, BMEYE, BrainScope) and persist in the market today. Several of them were taken from product concept, through development, clinical validation and FDA clearance. “Unmet Clinical Need – Elegant Technological Solution – Cogent Business Model” are the earmarks Dr. Combs looks for in life sciences entrepreneurship and what drew him to MC10.